- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
U.S. Diagnostic reports Q2 profit
The financial picture is beginning to solidify at imaging services firm U.S. Diagnostic of West Palm Beach, FL. Although the company this month reported second-quarter (end-June) financial results that included a 7% revenue decline, the company boosted
The financial picture is beginning to solidify at imaging services firm U.S. Diagnostic of West Palm Beach, FL. Although the company this month reported second-quarter (end-June) financial results that included a 7% revenue decline, the company boosted its operating income over the previous quarter, and a one-time gain helped propel USDL's net income numbers into the black.
For the period, USDL posted revenues of $52.5 million, compared with $56.4 million in the second quarter of 1997. The company had net income of $3.4 million, a figure that included a one-time gain of $5.8 million due to the sale of its Medical Diagnostics subsidiary to Alliance Imaging of Anaheim, CA. USDL posted a net loss of $11.9 million in the same period the year before.
USDL continues to try to improve its cash collection procedures, according to president and CEO Joseph Paul. The firm also plans to refinance its debt, a move that, once completed, will allow the firm to resume its acquisition strategy.
In other USDL news, the company entered into an equipment service and preferred vendor agreement with GE Medical Systems of Milwaukee. GE will provide service for equipment installed at USDL imaging centers across the U.S., and GE will be USDL's preferred vendor for new capital equipment purchases. USDL hopes the alliance will save the company $3.5 million annually once the agreement is fully operational.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
